Join
Live feed
·
PRReleasevia Quantisnow
Lipocine Inc. logo

Lipocine's LPCN 1144 Met Non-Alcoholic Steatohepatitis ("NASH") Resolution Regulatory Endpoint in Phase 2 LiFT Study

ByQuantisnow·Wall Street's wire, on your screen.
LPCN· Lipocine Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LPCN (Lipocine Inc.) and more on Quantisnow.